Adiv has been involved in aging research since 2008 and has published more than 40 papers in scientific journals related to aging, age-related disease, and regenerative medicine. Since completing his Ph.D. in Physiological Sciences at the University of Arizona in 2014 and finishing a postdoctoral research fellowship in the Ophthalmology Department at the Mayo Clinic in 2015, Adiv's research has focused on the underlying biology of aging and aging biomarkers. This research combined with his passion for healthy aging led him to join the longevity technology company Tally Health, where he serves as the Head of Scientific Affairs and Education.

Aging biomarkers and the quest to measure biological age

While biological age is useful as an abstract concept and allows us to conceptualize why people age so differently, it is not something that is currently quantifiable. Instead, we have a loose collection of validated aging biomarkers, including select next-generation aging clocks, that provide disparate insights into aspects of aging. Given the lengthy lag between discovery and translation as well as the infeasibility of conducting human lifespan studies, finding a way to truly measure biological age would massively accelerate testing of interventions aimed at enhancing longevity.

To be announced

https://tallyhealth.com/